SCIASCIA THOMAS — SEC Form 4 filings
SEC reporting owner CIK 1229946. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-20.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-16 to 2026-02-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 104,000 shares, $289,585 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 53,368 shares @ $2.55 ($136,110) in Trevi Therapeutics, Inc., filed 2024-05-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. (TRVI) | Chief Scientific Officer | 9 | — | 6 legs · 104,000 sh · $289,585 | 17 |
Form 4 filings — SCIASCIA THOMAS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 2,631 @ $1.43 · Sale (S): 2,631 @ $6.60 · Option exercise (M): 2,631 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 116,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 16,496 @ $1.43 · Sale (S): 16,496 @ $2.96 · Option exercise (M): 16,496 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 100 @ $1.43 · Sale (S): 100 @ $2.75 · Option exercise (M): 12,745 @ $1.43 · Sale (S): 12,745 @ $2.79 · Option exercise (M): 18,660 @ $1.43 · Sale (S): 18,660 @ $2.76 · +3 more | EDGAR |
| 2024-05-31 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 59,354 @ $2.19 · Sale (S): 53,368 @ $2.55 · Option exercise (M): 59,354 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1229946 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →